NB
WST icon

Norinchukin Bank’s West Pharmaceutical WST Stock Holding History

Norinchukin Bank’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Sell
3,882
-46
-1% -$14.1K 0.01% 400
2026
Q1 		$985K Buy
3,928
+18
+0.5% +$4.48K 0.01% 441
2025
Q4 		$1.08M Buy
3,910
+195
+5% +$53.3K 0.01% 436
2025
Q3 		$975K Buy
3,715
+10
+0.3% +$2.43K 0.01% 432
2025
Q2 		$811K Buy
3,705
+97
+3% +$20.7K 0.01% 447
2025
Q1 		$808K Buy
3,608
+457
+15% +$126K 0.01% 424
2024
Q4 		$1.03M Buy
3,151
+213
+7% +$67K 0.02% 352
2024
Q3 		$882K Buy
2,938
+361
+14% +$111K 0.02% 369
2024
Q2 		$849K Buy
2,577
+136
+6% +$48.1K 0.02% 333
2024
Q1 		$966K Sell
2,441
-29
-1% -$10.7K 0.03% 308
2023
Q4 		$870K Sell
2,470
-59
-2% -$20.9K 0.02% 320
2023
Q3 		$949K Sell
2,529
-798
-24% -$309K 0.02% 306
2023
Q2 		$1.27M Sell
3,327
-888
-21% -$317K 0.02% 380
2023
Q1 		$1.46M Buy
4,215
+142
+3% +$41.5K 0.03% 309
2022
Q4 		$959K Sell
4,073
-626
-13% -$148K 0.02% 371
2022
Q3 		$1.16M Buy
4,699
+351
+8% +$107K 0.02% 349
2022
Q2 		$1.31M Sell
4,348
-2,389
-35% -$777K 0.03% 316
2022
Q1 		$2.77M Buy
6,737
+454
+7% +$178K 0.04% 268
2021
Q4 		$2.95M Sell
6,283
-33
-0.5% -$14.2K 0.04% 238
2021
Q3 		$2.68M Buy
6,316
+197
+3% +$83K 0.04% 239
2021
Q2 		$2.2M Sell
6,119
-35
-0.6% -$11.6K 0.03% 267
2021
Q1 		$1.73M Buy
6,154
+104
+2% +$29.8K 0.02% 301
2020
Q4 		$1.71M Sell
6,050
-146
-2% -$41K 0.02% 279
2020
Q3 		$1.7M Buy
6,196
+95
+2% +$25.1K 0.03% 258
2020
Q2 		$1.39M Buy
+6,101
New +$1.2M 0.02% 286

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Norinchukin Bank's WST Position: Q2 2026 in Review

Norinchukin Bank reduced its West Pharmaceutical (WST) stake by 1.2% in Q2 2026, selling an estimated $14.1K and leaving 3,882 shares worth $1.39M. The position accounts for 0.01% of the portfolio, ranked #400.

Norinchukin Bank first reported a position in WST in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.95M in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Norinchukin Bank held 3,882 shares of West Pharmaceutical worth $1.39M as of Q2 2026.
  • Norinchukin Bank sold 46 West Pharmaceutical shares in Q2 2026, an estimated $14.1K.
  • West Pharmaceutical made up 0.01% of Norinchukin Bank's portfolio in Q2 2026, its #400 holding.
  • Norinchukin Bank first reported a position in West Pharmaceutical in Q2 2020 and has held it in 25 quarters since.
  • Norinchukin Bank's West Pharmaceutical position peaked at $2.95M in Q4 2021.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Norinchukin Bank's 13F filing for Q2 2026, filed 14 Aug 2026.